Image

Clinical Echocardiography and S' Wave for Early Recognition of Acute Coronary Syndrome in the Emergency Department, A Prospective Study

Clinical Echocardiography and S' Wave for Early Recognition of Acute Coronary Syndrome in the Emergency Department, A Prospective Study

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this prospective observational study is to assess the diagnostic accuracy of the tissue Doppler imaging (TDI) S' wave in detecting acute coronary syndrome (ACS) in adult patients presenting to the emergency department (ED) with acute chest pain. This study focuses on patients aged 18 years or older, who require continuous cardiac monitoring but do not show ST-elevation myocardial infarction (STEMI) on their initial ECG.

The main questions it aims to answer are:

  • Can TDI S' wave velocity serve as an early diagnostic marker for ACS in the emergency department?
  • How does the diagnostic performance of TDI S' compare with other echocardiographic markers (MAPSE, TAPSE, and diastolic parameters such as E, E', A, E/A, E/E')?
  • Do demographic factors (age, sex, BMI, echogenicity) influence the diagnostic accuracy of echocardiographic parameters for ACS? If there is a comparison group: Researchers will compare TDI S' wave velocity findings with the final adjudicated diagnosis of ACS (determined after 3 months) to evaluate its sensitivity and specificity.

Eligibility

Inclusion Criteria:

  • Age ≥18 years
  • Presenting to the emergency department (ED) with acute chest pain
  • No ST-elevation myocardial infarction (STEMI) on initial ECG
  • Requiring continuous cardiac monitoring based on triage decision
  • Able to provide informed consent (written consent required)

Exclusion Criteria:

  • Known pre-existing cardiomyopathy (e.g., hypertrophic cardiomyopathy, dilated cardiomyopathy)
  • Severe valvular heart disease
  • Left bundle branch block (LBBB) or presence of a pacemaker
  • Arrhythmias (e.g., atrial fibrillation, frequent premature ventricular contractions)
  • Cardiac arrest or cardiogenic shock at presentation
  • Pulmonary hypertension
  • Pericardial effusion or tamponade
  • Non-cardiac cause of chest pain suspected as the primary diagnosis
  • Language barrier preventing informed consent (study materials available in English, French, and Dutch)

Study details
    Acute Coronary Syndrome
    Myocardial Infarction (MI)
    Non-ST Elevation Myocardial Infarction
    Unstable Angina
    Echocardiography
    Tissue Doppler
    Emergency Medicine
    Cardiac Function Tests

NCT06860997

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.